283 related articles for article (PubMed ID: 31606233)
1. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis.
Vangala C; Niu J; Montez-Rath ME; Yan J; Navaneethan SD; Winkelmayer WC
Am J Kidney Dis; 2020 Mar; 75(3):351-360. PubMed ID: 31606233
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.
Vangala C; Niu J; Lenihan CR; Mitch WE; Navaneethan SD; Winkelmayer WC
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1534-1541. PubMed ID: 30262672
[TBL] [Abstract][Full Text] [Related]
3. Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids.
Vangala C; Niu J; Montez-Rath ME; Yan J; Navaneethan SD; Naik AD; Winkelmayer WC
J Am Soc Nephrol; 2020 Jun; 31(6):1325-1334. PubMed ID: 32371535
[TBL] [Abstract][Full Text] [Related]
4. Use of Selective Serotonin Reuptake Inhibitors and Risk of Hip Fracture in the Elderly: A Case-Control Study in Taiwan.
Hung SC; Lin CH; Hung HC; Lin CL; Lai SW
J Am Med Dir Assoc; 2017 Apr; 18(4):350-354. PubMed ID: 28159466
[TBL] [Abstract][Full Text] [Related]
5. Trends in hip fracture rates in US hemodialysis patients, 1993-2010.
Arneson TJ; Li S; Liu J; Kilpatrick RD; Newsome BB; St Peter WL
Am J Kidney Dis; 2013 Oct; 62(4):747-54. PubMed ID: 23631997
[TBL] [Abstract][Full Text] [Related]
6. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Assimon MM; Brookhart MA; Flythe JE
J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor use in hip fracture patients: a Danish nationwide prevalence study.
Bruun SB; Petersen I; Kristensen NR; Cronin-Fenton D; Pedersen AB
Acta Orthop; 2019 Feb; 90(1):33-39. PubMed ID: 30526179
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective serotonin reuptake inhibitors and other antidepressant drugs on the risk of hip fracture: a case-control study in an elderly Mediterranean population.
Gorgas MQ; Torres F; Vives R; Lopez-Rico I; Capella D; Pontes C
Eur J Hosp Pharm; 2021 Jan; 28(1):28-32. PubMed ID: 33355280
[TBL] [Abstract][Full Text] [Related]
9. Statin use and hip fractures in U.S. kidney transplant recipients.
Vangala C; Lenihan CR; Montez-Rath ME; Nair SS; Navaneethan SD; Ramanathan V; Winkelmayer WC
BMC Nephrol; 2017 May; 18(1):145. PubMed ID: 28460645
[TBL] [Abstract][Full Text] [Related]
10. Fractures in patients with rheumatoid arthritis and end-stage renal disease.
Peterkin-McCalman R; Waller JL; Le B; Oliver AM; Manning E; Elam RE; Kheda M; Nahman NS; Carbone LD
Arch Osteoporos; 2020 Sep; 15(1):146. PubMed ID: 32948922
[TBL] [Abstract][Full Text] [Related]
11. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
12. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
Diem SJ; Blackwell TL; Stone KL; Yaffe K; Haney EM; Bliziotes MM; Ensrud KE
Arch Intern Med; 2007 Jun; 167(12):1240-5. PubMed ID: 17592096
[TBL] [Abstract][Full Text] [Related]
13. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry.
Bakken MS; Engeland A; Engesæter LB; Ranhoff AH; Hunskaar S; Ruths S
Age Ageing; 2013 Jul; 42(4):514-20. PubMed ID: 23438446
[TBL] [Abstract][Full Text] [Related]
15. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.
Liu B; Anderson G; Mittmann N; To T; Axcell T; Shear N
Lancet; 1998 May; 351(9112):1303-7. PubMed ID: 9643791
[TBL] [Abstract][Full Text] [Related]
16. Impact of selective serotonin reuptake inhibitors in the veteran population: 10-year risk outcomes.
Brinton DL; Simpson AN; Fominaya CE; LaRue AC
J Comp Eff Res; 2019 Apr; 8(6):431-440. PubMed ID: 30855179
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study.
Nørgaard M; Jacobsen J; Gasse C; Pedersen L; Mortensen PB; Sørensen HT
J Clin Psychopharmacol; 2007 Jun; 27(3):259-62. PubMed ID: 17502772
[TBL] [Abstract][Full Text] [Related]
18. Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis.
Becker C; Jick SS; Meier CR
Ophthalmology; 2017 Nov; 124(11):1635-1639. PubMed ID: 28571893
[TBL] [Abstract][Full Text] [Related]
19. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.
Hubbard R; Farrington P; Smith C; Smeeth L; Tattersfield A
Am J Epidemiol; 2003 Jul; 158(1):77-84. PubMed ID: 12835289
[TBL] [Abstract][Full Text] [Related]
20. The utility of FRAX® in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study.
Przedlacki J; Buczyńska-Chyl J; Koźmiński P; Niemczyk E; Wojtaszek E; Gieglis E; Żebrowski P; Podgórzak A; Wściślak J; Wieliczko M; Matuszkiewicz-Rowińska J;
Osteoporos Int; 2018 May; 29(5):1105-1115. PubMed ID: 29411069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
